Skip to main content
SpringerLink
Log in

Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies

Effects on clinicopathological features and immunoregulatory genes

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Controlled trials with intravenous immunoglobulin (IVIg) were conducted in patients with Stiff-Person Syndrome (SPS) and dermatomyositis (DM), two humorally mediated neurological disorders, and in inclusion body myositis (IBM), a T-cell-mediated inflammatory myopathy. The clinical efficacy was compared with alterations on tissue expression of complement, cytokines, chemokines, adhesion molecules, and immunoregulatory genes.

The following patients were randomized in three separate trials to receive IVIg or placebo for 3 mo: (a) 16 patients with anti-GAD antibody-positive SPS; (b) 15 patients with DM resistant to therapies; and (c) 19 patients with IBM. After a washout, they crossed to the alternative therapy for another 3 mo. Efficacy was based on the difference in the respective disease scores from baseline to the second and third month of the infusions. In patients with SPS and DM, the scores changed positively and significantly from months 1 through 3, but returned to baseline when the patients crossed to placebo. In contrast, the scores in the placebo-randomized group remained constant or worsened from months 1 to 3, but improved significantly after crossing to IVIg. The muscle scores of patients with IBM did not significantly change between IVIg or placebo. In SPS, the anti-GAD65 antibody titers declined after IVIg but not after placebo. In DM, there was reduction of complement consumption, interception of membranolytic attack complex formation, downregulation of inflammation, fibrosis, cytokines, chemokines and adhesion molecules, and alterations in thousands of immunoregulatory genes.

We conclude that IVIg is a safe and effective therapy for patients with SPS and DM unresponsive to other agents. In tissues, IVIg restores tissue cytoarchitecture by suppressing the inflammatory mediators at the protein, mRNA, and gene level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ellis, M. T. and Atkinson, A. M. (1996), Nat Med 2, 148–153.

    Article  PubMed  CAS  Google Scholar 

  2. Daw, K., Ujihara, N., Atkinson, M., and Powers, A. C. (1996), J Immunol 156, 818–825.

    PubMed  CAS  Google Scholar 

  3. Solimena, M., Folli, F., Aparisi, R., Pozza, G., and De Camilli, P. (1990), N Engl J Med 322, 1555–1560.

    Article  PubMed  CAS  Google Scholar 

  4. Dalakas, M. C., Fujii, M., Li, M., and McElroy, B. (2000), Neurology 55, 1531–1535.

    PubMed  CAS  Google Scholar 

  5. Dalakas, M. C. (1999), Ann Intern Med 131, 522–530.

    PubMed  Google Scholar 

  6. Dalakas, M. C., Li, M., Fujii, M., and Jacobowitz, D. M. (2001), Neurology 57, 780–785.

    PubMed  CAS  Google Scholar 

  7. Murinson, B. B., Butler, M., Marfurt, K., et al. (2004), Neurology 63, 2146–2148.

    PubMed  CAS  Google Scholar 

  8. Peltola, J., Kulmala, P., Isojarvi, J., et al. (2000), Neurology 55, 46–50.

    PubMed  CAS  Google Scholar 

  9. Honnorat, J., Saiz, A., Giometto, B., et al. (2001), Arch Neurol 58, 225–230.

    Article  PubMed  CAS  Google Scholar 

  10. Dalakas, M. C. (2005), J Neurol 252 Suppl 1, i19-i25.

    Article  PubMed  CAS  Google Scholar 

  11. Pearce, D. A., Atkinson, M., and Tagle, D. A. (2004), Neurology 63, 2001–2005.

    PubMed  CAS  Google Scholar 

  12. Dalakas, M. C. (1999), Ann Intern Med 131, 523–524.

    Google Scholar 

  13. Vasconcelos, O. M. and Dalakas, M. C. (2003), Curr Treat Options Neurol 5, 79–90.

    Article  PubMed  Google Scholar 

  14. Barker, R. A., Revesz, T., Thom, M., Marsden, C. D., and Brown, P. (1998), J Neurol Neurosurg Psychiatry 65, 633–640.

    PubMed  CAS  Google Scholar 

  15. Dalakas, M. C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., and McElroy, B. (2001), N. Engl J Med 345, 1870–1876.

    Article  PubMed  CAS  Google Scholar 

  16. Dinkel, K. Meinck, H. M., Jury, K. M., Karges, W., and Richter, W. (1998), Ann. Neurol 44, 194–201.

    Article  PubMed  CAS  Google Scholar 

  17. Ishida, K., Mitoma, H., Song, S.-Y., et al. (1999), Ann Neurol 46, 263–267.

    Article  PubMed  CAS  Google Scholar 

  18. Levy, L. M., Levy-Reis, I., Fujii, M., and Dalakas, M. C. (2005), Arch Neurol 62, 970–974.

    Article  PubMed  Google Scholar 

  19. Amato, A. A., Cornman, E. W., and Kissel, J. T. (1994), Neurology 44, 1652–1654.

    PubMed  CAS  Google Scholar 

  20. Barker, R. A. and Marsden, C. D. (1997), J Neurol Neurosurg Psychiatry 62, 426–427.

    PubMed  CAS  Google Scholar 

  21. Dalakas, M. C. (2004), JAMA 291, 2367–2375.

    Article  PubMed  CAS  Google Scholar 

  22. Dalakas, M. C. (2004), Pharmacol Therapeutics 102, 177–193.

    Article  CAS  Google Scholar 

  23. Weinberger, D. R. (2001), N Engl J Med 344, 1247–1249.

    Article  PubMed  CAS  Google Scholar 

  24. Dalakas, M. C. (1991), N Engl J Med 325, 1487–1498.

    Article  PubMed  CAS  Google Scholar 

  25. Dalakas, M. C. and Hohlfeld, R. (2003), Lancet 362, 971–982.

    Article  PubMed  CAS  Google Scholar 

  26. Dalakas, M. C. (2004), Curr Opin Neurol 17, 561–567.

    Article  PubMed  CAS  Google Scholar 

  27. Dalakas, M. C. (2003), Sem Neurol 23, 199–206.

    Article  Google Scholar 

  28. Dalakas, M. C. (1989), Curr Opin Rheumatol 1, 443–449.

    PubMed  CAS  Google Scholar 

  29. Miller, F. W., Leitman, S. F., Cronin, M. E., et al. (1992), N Engl J Med 326, 1380–1384.

    Article  PubMed  CAS  Google Scholar 

  30. Cherin, P., Herson, S., Wechsler, B., et al. (1991), Am J Med 91, 162–168.

    Article  PubMed  CAS  Google Scholar 

  31. Lang, B. A., Laxer, R. M., Murphy, G., Silverman, E. D., and Roifman, C. M. (1991), Am J Med 91, 169–172.

    Article  PubMed  CAS  Google Scholar 

  32. Jann, S., Beretta, S., Moggio, M., Adobbati, L., and Pellegrini, G. (1992), J Neurol Neurosurg Psychiatry 55, 60–64.

    PubMed  CAS  Google Scholar 

  33. Soueidan, S. A. and Dalakas, M. C. (1993), Neurology 43, 876–879.

    PubMed  CAS  Google Scholar 

  34. Illa, I., Gallardo, E., Gimeno, R., Serrano, C., Ferrer, I., and Juarez, C. (1997), Am J Pathol 151, 81–88.

    PubMed  CAS  Google Scholar 

  35. Dalakas, M. C., Illa, I., Dambrosia, J. M., et al. (1993), N Engl J Med 329, 1993–2000.

    Article  PubMed  CAS  Google Scholar 

  36. Basta, M. and Dalakas, M. C. (1994), J Clin Invest 94, 1729–1735.

    Article  PubMed  CAS  Google Scholar 

  37. Amemiya, K., Semino-Mora, C., Granger, R. P., and Dalakas, M.C. (2000), Clin Immunol 94, 99–104.

    Article  PubMed  CAS  Google Scholar 

  38. Raju, R. and Dalakas, M. C. (2005), Brain 128, 1887–1896.

    Article  PubMed  Google Scholar 

  39. Sekul, E. A. and Dalakas, M. C. (1993), Semin Neurol 13, 256–263.

    PubMed  CAS  Google Scholar 

  40. Dalakas, M. C. (2002), Revue Neurol 158, 948–958.

    CAS  Google Scholar 

  41. Griggs, R. C., Askanas, V., DiMauro, S., et al. (1995), Ann Neurol 38, 705–715.

    Article  PubMed  CAS  Google Scholar 

  42. Sivakumar, K. and Dalakas, M. C. (1997), Curr Opin Neurol 10, 413–420.

    Article  PubMed  CAS  Google Scholar 

  43. Askanas, V. and Engel, W. K. (2002), Curr Opin Neurol 15, 525–531.

    Article  PubMed  Google Scholar 

  44. Dalakas, M. C. (2004), Curr Opin Neurol 17, 561–567.

    Article  PubMed  CAS  Google Scholar 

  45. Amemiya, K., Granger, R. P., and Dalakas, M. C. (2000), Brain 123, 2030–2039.

    Article  PubMed  Google Scholar 

  46. Koffman, B. M., Sivakumar, K., Simonis, T., Stroncek, D., and Dalakas, M. C. (1998), J Neuroimmunol 84, 139–142.

    Article  PubMed  CAS  Google Scholar 

  47. Koffman, B. M., Rugiero, M., and Dalakas, M. C. (1998), Muscle Nerve 21, 115–117.

    Article  PubMed  CAS  Google Scholar 

  48. Murata, K. and Dalakas, M. C. (1999), Am J Pathol 155, 453–460.

    PubMed  CAS  Google Scholar 

  49. Schmidt, J., Rakocevic, G., Raju, R., and Dalakas, M. C. (2004), Brain 127, 1182–1190.

    Article  PubMed  Google Scholar 

  50. Raju, R., Vasconcelos, O. M., Semino-Mora, C., Granger, R. P., Dalakas, M. C. (2003), J Neuroimmunol 141, 125–131.

    Article  PubMed  CAS  Google Scholar 

  51. Amato, A. A., Barohn, R. J., Jackson, C. E., et al. (1993), Neurology 43, 876–879.

    Google Scholar 

  52. Dalakas, M. C., Sonies, B., Dambrosia, J., Sekul, E., Cupler, E., and Sivakumar, K. (1997), Neurology 48, 712–716.

    PubMed  CAS  Google Scholar 

  53. Cherin, P., Pelletier, S., Teixeria, A., et al. (2002), Neurology 58, 326.

    PubMed  CAS  Google Scholar 

  54. Walter, M. C., Lochmuller, H., Toepfer, M., et al. (2000), J Neurol 247, 22–28.

    Article  PubMed  CAS  Google Scholar 

  55. Dalakas, M. C., Sonies, B., Koffman, B., et al. (2001), Neurology 56, 323–327.

    PubMed  CAS  Google Scholar 

  56. Cherin, P., Herson, S., Wechsler, B., et al. (1991), Am J Med 91, 162–168.

    Article  PubMed  CAS  Google Scholar 

  57. Jan, S., Beretta, S., Moggio, M., Alobbati, L., and Pellgrini, G. (1992), J Neurol Neurosurg Psychiatry 55, 60–64.

    Article  Google Scholar 

  58. Lang, B., Laxer, R. M., Murphy, G., Silverman, E. D., and Roitmani, C. M. (1991), Am J Med 91, 169–172.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD

    Marinos C. Dalakas

Authors
  1. Marinos C. Dalakas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalakas, M.C. Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies. Clinic Rev Allerg Immunol 29, 255–269 (2005). https://doi.org/10.1385/CRIAI:29:3:255

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:29:3:255

Index Entries

Search

Navigation